AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
Multiple sclerosis is a chronic illness that affects the lives of more than 2.3 million people globally. There is no proven cause and, for now, no known cure. It is a debilitating, progressive and ...
The rapid proliferation of high-efficacy disease-modifying therapies for multiple sclerosis (MS) has revolutionized the treatment landscape, yet significant gaps remain in how health systems organize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results